Mobileodt

We wish all our followers a wonderful holiday season. May this season be full of light and laughter for you and your family.
from all of us at MobileODT.

New Feature Alert!
We are pleased to share that a new screen mirroring feature is now available on the MobileODT next-gen .
This latest innovation allows physicians to present the cervix image on an external screen, improving the examination experience and educating patients on their inner anatomy.
We thank our physician partners for your trust in MobileODT technology and look forward to delivering more exciting product features to support you in your important task to advance .
Please visit our website to learn more: https://www.mobileodt.com/products/eva-pro/

Happy Thanksgiving!
Sending all our customers, partners, friends, and followers warm greetings from heart to heart.
May Thanksgiving and the rest of the year remind us to be grateful for what we have.
Happy Thanksgiving from MobileODT.

Wishing all our US partners, friends, and followers a very Happy Independence Day!
May you enjoy this significant day among loved ones and celebrate independence with glee!
Congratulations and best wishes from all of us at MobileODT

We are very honored and proud to announce the MobileODT involvement in the largest cervical cancer and breast cancer screening and treatment program in Africa.
As part of the program, President Tshisekedi and the Ministry of Health of the Democratic Republic of Congo aim to establish over 1,000 women’s health clinics, enhancing women’s healthcare in the DRC, and positioning the country as a leader in women’s health in Africa.
"We are extremely proud that the MobileODT screening and treatment technologies have been selected to be part of this endeavor in the DRC," says Leon-Ariel Boston, MobileODT’s CEO, "our turnkey screen and treat offering, from HPV testing to visual inspection and thermocoagulation treatment offers a complete single visit solution, overcoming the two main issues in the developing world: accessibility and loss to follow-up. We are privileged to contribute to saving lives and changing outcomes for so many women."
Thank you HealthCare Middle East & Africa for featuring this important initiative.

DRC President backs the rollout of the country’s largest cervical and breast cancer screening program | HealthCare Middle East & Africa Magazine DRC—President Felix Tshisekedi Tshilombo of the Democratic Republic Congo (DRC), has given his full backing to phase one of Cingulate Medical and MobileODT’ ...

Please meet the MobileODT , a complete point of-care thermocoagulation treatment for pre-cancerous lesions.

ThermoGlide offers the physician an immediate precancer treatment option within a single visit, addressing one of the most acute problems of loss to follow-up. ThermoGlide allows the clinician to treat lesions that appear during a cervical examination, safely and effectively, with minimal side effects. The procedure does not require general anesthetic

“Thermocoagulation devices are used to treat precancerous lesions of the cervix. A benefit over cryotherapy is that this device is portable, light, and does not require any gas or electricity" say Dr. Lindsey Beffa and Dr Katina Robinson, Gynecologic Oncologists at Clinton Health.

Visit our website to learn more: https://www.mobileodt.com/products/thermo-glide/

Join our upcoming webinar in Spanish!

Pablo Russo, M.D., especialista en ginecología y obstetricia analiza nuevas opciones para la prevención del cáncer de cuello uterino.
- Cáncer Cervicouterino en América Latina- el desafío y la oportunidad
- Nuevos métodos de diagnóstico del cáncer de cuello uterino
- Opciones en el tratamiento de lesiones premalignas.
- Revisión del novedoso colposcopio digital EVA Pro y el termocoagulador ThermoGlide para lesiones precancerosas.
- Prueba de antígeno VPH Delphi con resultados inmediatos

RSVP at : https://zoom.us/webinar/register/1616862580356/WN_FUnkisnmS8KZVrJny0T80A

Symbiosis Medica

We are happy to share that MobileODT CEO Leon A. Boston will take part in a MedTech GoToMarket Executive Meet-Up organized by MedTech Marketing at Scale and Reinhold Cohn Group קבוצת ריינהולד כהן.
Leon will be joining health tech CEOs, Founders, Investors, and Industry Experts Panel that will discuss how to best prepare for the coming year and overcome the challenges posed by a recession. Assaf Barnea Daniella Gilboa Olga Rosenman Dalia Rivenzon-Segal Eli Yered.
Leon will share his vast experience as a consummate CEO and entrepreneurial business leader. He will discuss how to pivot a disrupted company, analyze and evaluate the market and identify the new potential for growth.
Come meet Leon-Ariel Boston and hear the mobileODT case study of transition into a multi-product leader in .

RSVP at:

MedTech Executive Meet-Up: How to Generate Growth During Recession? Live Meet-Up Event. MedTech Investors, Founders, CEOs, and Industry Experts meet to discuss trends, challenges, and opportunities in 2023.

Happy International Women's Day to all the inspiring women out there!
mobileODT is proud to lead the way in helping hundreds of thousands of women worldwide to prevent cervical cancer with early detection and treatment.
Over 400,000 exams have been taken to date with the mobileODT EVA software and their results and clinical findings are documented on the EVA portal.
This vast database provides invaluable insights into colposcopic examination and findings. We will be sharing the data analysis in our upcoming posts.
Stay tuned!

Excited to kick off Arab Health together with our valued partners GENWORKS Health .

https://m.facebook.com/story.php?story_fbid=592194519588341&id=100063933946955&mibextid=Nif5oz

Exciting News! MobileODT is a finalist in Leading International Trade Fair 14th Innovation World Cup Series.
Selected from 300+ companies, we are excited to be among the top Top12 Health Techpreneurs in 2022, who will be pitching at Medica.

Join the innovation! Visit us at Medica to learn how we are redefining and .
Book a meeting to discuss collaboration: https://lnkd.in/dZUCvm4F



Congrats to our fellow finalists AURIMOD GmbH, breathe ilo GmbH, Mane Biotech, Netsensing Technology, OrCam , PulseOn, Startup Campus, ViewMind Inc., HammTek and Wheelstair

Trick or treat? The answer is easy with MobileODT!
Pumpkins are carved, ghosts are seen, the hour is here, happy Halloween!

MobileODT launches new cervical cancer screening and treatment solutions at - Leading International Trade Fair.
We are proud to create a unique paradigm in diagnosis and treatment. Upgrading our offering and evolving as a complete solution for cervical cancer and .
Meet us at to discover our latest innovations and discuss business opportunities.
Follow the link to schedule a meeting: https://lnkd.in/dZUCvm4F

Did you know that every 68 seconds an American is sexually assaulted?
mobileODT is proud to make an impact in Sexual Assault Forensics with EVASane, the #1 Sexual Forensics technology in the US.
Over 332,000 images were taken with EVASane , sexual assault forensics visualization, and documentation.
Make an impact with EVASane. Follow the link to learn more: https://www.mobileodt.com/products/eva-sane/

We wish all our customers, partners, friends, and followers a Happy Labor Day! Thank you, for your tireless work to advance women's health.

We are happy to share that MobileODT CEO Leon-Ariel Boston will speak tomorrow at the WHII Women's Health Innovations and Inventions Congress.
Join Mr. Boston to hear about our latest innovations in cervical cancer screening and treatment and the role of Artificial intelligence in combating cervical cancer.

We are excited to share that MobileODT will be introducing a line of the latest product at the WHII Women's Health Innovations and InventionsCongress.
Visit our booth to discover the next-gen solutions for digital and .
These new products are part of our strategy to provide a comprehensive, high-technology solution for .

Excited to share a new feature on the that will allow you to take better images for .

We have added a flash option that enhances both image quality and color, especially when used in darker surroundings.

We hope that this new feature will be useful for your forensic activity.
Any feedback or comments are most welcome!

We are thrilled to share that MobileODT VisualCheck Artificial Intelligence technology for cervical cancer screening and diagnosis will be the focus of two abstract presentations at the EFC - European Federation for Colposcopy 2022 Annual Meeting.
Evaluation studies performed by Dr. Golubenko and A. Lokshina present VisualCheck efficacy in diagnosing cervical pre-cancer, as compared to alternative modalities.
Follow the link for more info and registration: https://lnkd.in/db2yBhFX

Cervical cancer results in over 311,000 annual deaths, making it the 4th most common cancer among women worldwide. As early detection can make a huge impact, the World Health Organization made a strategic decision to embark on a global 10-year plan to eliminate cervical cancer through effective vaccination, screening, and treatment.
In honor of , we look at how technological innovation is helping national cervical cancer programs meet these ambitious goals.
Read more on our new blog >>
https://www.mobileodt.com/blog/eva-leads-the-way-on-world-health-day-2022/

We are excited to share our brand new blog by Professor Emeritus Paul Blumenthal, Stanford University School of Medicine dedicated to novel developments in cervical cancer prevention.
Despite improvements in a variety of screening methodologies, the rates of cervical cancer have increased by 45% in the last 30 years. In recent years there has been a shift to recognize that defeating cervical cancer has three essential components: the screening coverage, the treatment effectiveness, and the link between screening and treatment.
Read about the latest innovations in cervical cancer screening and treatment:
https://www.mobileodt.com/blog/the-future-of-cervical-cancer-prevention/

It''s time to advance to a novel digital technology in .
Be at the forefront of women's health with the MobileODT EVA mini colposcope powered by telehealth and AI capabilities.
Visit our website to learn more: https://www.mobileodt.com/

Happy Valentines Day from all of us at MobileODT!

We look forward to further advancing women's health, and transforming outcomes for women worldwide, so that they can enjoy these beautiful moments with their Valentine.

What an amazing case study of EVA Colpo roll-out in the Russian Market.
The foundation was laid in the Oryol Colposcopy Center, when 34 patients were examined in one day.
The device was successfully tested in St. Petersburg using telemedicine in real-time. This made it possible to expand the boundaries and use the device in a distance of thousands of kilometers, in Uzbekistan.
Dr. Aleksey Golubenko, Gynecologist Oncologist, performed a remote colposcopy consultation and diagnostics using the EVA device.
"It became a reality thanks to mobile Colposcopy technology," says Dr. Golubenko.

We are thrilled at this success and would like to thank Dr. Golubenko and our partners in Russia - Emma Soboleva and the MMC Group.

Excited to release the next-generation AI Hybrid Algorithm to the ROW markets!
This coincides perfectly with cervical cancer awareness and MobileODT commitment to advancing women's health.



https://finance.yahoo.com/news/femtech-company-mobileodt-announces-release-100000103.html